Amifampridine is mainly used to treat many rare muscle diseases. In the United States, aminopyridine is being studied for the treatment of Lambert-Eaton myasmus syndrome (LEMS). Amifampridine is also used to treat many congenital myasthenia syndromes, particularly those with defects in choline acetyltransferase, downstream kinase 7, and any type of defects leading to "fast track" defects.

446254-47-3

C5H10N3O4P

207.12

BRN0110232;SC10;BRN 0110232;NSC 521760;3,6-DAP;BRN-0110232;Amifampridine phosphate

(< 1 mg/ml refers to the product slightly soluble or insoluble )
Powder: -20°C for 3 years
In solvent: -80°C for 2 years